CONSIDERATIONS TO KNOW ABOUT HEMGENIX

Number of eligible patients: CDEC discussed the uncertainty in the number of individuals with moderately serious to serious hemophilia B in Canada eligible for etranacogene dezaparvovec. Scientific experts consulted by CADTH indicated that some individuals who are labeled as obtaining delicate or reasonable condition might have a serious bleeding p